Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Significant prognostic factors for completely resected pN2 non-small cell lung cancer without neoadjuvant therapy.

Significant prognostic factors for completely resected pN2 non-small cell lung cancer without neoadjuvant therapy. Ann Thorac Cardiovasc Surg. 2015; 21(4):345-53.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.